West Pharmaceutical Services Inc (WST)
385.60
-4.60
(-1.18%)
USD |
NYSE |
Apr 24, 16:00
385.60
0.00 (0.00%)
After-Hours: 16:35
West Pharmaceutical Services Cash from Financing (TTM): -459.60M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -459.60M |
| September 30, 2023 | -279.60M |
| June 30, 2023 | -332.50M |
| March 31, 2023 | -191.90M |
| December 31, 2022 | -293.60M |
| September 30, 2022 | -290.30M |
| June 30, 2022 | -220.90M |
| March 31, 2022 | -184.40M |
| December 31, 2021 | -168.10M |
| September 30, 2021 | -170.60M |
| June 30, 2021 | -172.00M |
| March 31, 2021 | -173.20M |
| December 31, 2020 | -137.10M |
| September 30, 2020 | -77.40M |
| June 30, 2020 | -70.60M |
| March 31, 2020 | -66.60M |
| December 31, 2019 | -36.80M |
| September 30, 2019 | -96.00M |
| June 30, 2019 | -85.50M |
| March 31, 2019 | -114.30M |
| December 31, 2018 | -80.70M |
| September 30, 2018 | -159.00M |
| June 30, 2018 | -172.10M |
| March 31, 2018 | -144.10M |
| December 31, 2017 | -109.00M |
| Date | Value |
|---|---|
| September 30, 2017 | -48.90M |
| June 30, 2017 | -60.90M |
| March 31, 2017 | -70.60M |
| December 31, 2016 | -113.90M |
| September 30, 2016 | -89.10M |
| June 30, 2016 | -104.50M |
| March 31, 2016 | -107.80M |
| December 31, 2015 | -41.50M |
| September 30, 2015 | -41.70M |
| June 30, 2015 | -21.30M |
| March 31, 2015 | -55.80M |
| December 31, 2014 | -30.80M |
| September 30, 2014 | -52.50M |
| June 30, 2014 | -39.40M |
| March 31, 2014 | -34.40M |
| December 31, 2013 | -5.10M |
| September 30, 2013 | -11.10M |
| June 30, 2013 | -6.50M |
| March 31, 2013 | 27.90M |
| December 31, 2012 | -3.40M |
| September 30, 2012 | -2.00M |
| June 30, 2012 | -3.60M |
| March 31, 2012 | -0.60M |
| December 31, 2011 | -24.70M |
| September 30, 2011 | -11.20M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-459.60M
Minimum
Dec 2023
-36.80M
Maximum
Dec 2019
-184.56M
Average
-172.00M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
| Becton Dickinson & Co | -2.286B |
| Abbott Laboratories | -7.091B |
| Masimo Corp | -57.10M |
| Merit Medical Systems Inc | 559.27M |
| Insulet Corp | -13.60M |